BDD Pharma

BDD Pharma

Eveloping and testing new drugs, particularly focusing on oral formulations and early-stage clinical trials.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
investor investor

€0.0

round
investor investor investor

€0.0

Valuation: €0.0

round
investor investor investor

€0.0

Valuation: €0.0

round

N/A

Seed
Total Funding000k
More about BDD Pharma
Made with AI
Edit

BDD Pharma specializes in providing tailored oral drug delivery solutions, leveraging its proprietary time-controlled release platform, OralogiK. The company operates in the pharmaceutical sector, focusing on accelerating the market entry of drug formulations through its advanced clinical trial methodologies. BDD Pharma serves pharmaceutical companies seeking to enhance their drug delivery systems, particularly in the solid oral dose sector. The business model revolves around licensing agreements and partnerships, enabling clients to achieve rapid proof of concept and competitive advantage. Revenue is generated through bespoke service offerings and technology licensing. Key clients include top pharmaceutical companies looking for innovative solutions in drug formulation and delivery. BDD Pharma's commitment to scientific excellence and client-centric values positions it as a strategic partner in the pharmaceutical industry.

Keywords: drug delivery, OralogiK, clinical trials, pharmaceutical, licensing, time-controlled release, bespoke solutions, market entry, solid oral dose, partnerships.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo